– ITALY, Milan – NanoPhoria, a pre-clinical stage biotech company that is developing a versatile, non-viral drug delivery platform based on inorganic nanoparticles and has a lead product for heart failure, today announced the appointments to its Board of Directors of Dr.…
– ITALY, Lomazzo – Directa Plus (LON: DCTA), a leading producer and supplier of graphene nanoplatelets-based products today announced the appointment of Sarah Cope to its Board as a Non-Executive director.…
– ITALY, Milan – CESI (Centro Elettrotecnico Sperimentale Italiano, Italian Experimental Electrotechnical Center) SpA today announced the appointment of Domenico Villani as its new CEO, taking over from Matteo Codazzi, who leaves the company.…
– ITALY, Lomazzo – Directa Plus (LON: DCTA), a leading producer and supplier of graphene nanoplatelets-based products, today announced the appointment of General (ret.)…
– ITALY, Milan – Genenta Science (NASDAQ: GNTA), a clinical-stage biotechnology company pioneering the development of hematopoietic stem progenitor cell immuno-gene therapy for cancer, today announced the nomination of Dr.…
